Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pracht

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trialJ-Y Blay, Q Devin, M Toulmonde, et al.
International Journal of Surgery (London, England)|April 4, 2024
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort studyM Mekkan-Bouv Hez, L Derbey, L de Mestier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
ESMO Open|March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARCC Cuvelier, M Brahmi, I Sobhani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2025
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trialJ-Y Blay, Q Devin, M Toulmonde, et al.
International Journal of Surgery (London, England)|April 4, 2024
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort studyM Mekkan-Bouv Hez, L Derbey, L de Mestier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
ESMO Open|March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARCC Cuvelier, M Brahmi, I Sobhani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Pageof 2